2025 HCPCS code Q2039

HCPCS code Q2039 represents an influenza virus vaccine (split virus), not otherwise specified, for intramuscular administration to individuals 3 years and older.

Follow CMS guidelines for HCPCS coding and reporting. Accurate documentation is essential for proper reimbursement.

Modifiers may apply depending on the circumstances of the service, including place of service, the type of provider, and whether the service is part of a global package. Always consult current modifier guidelines.

Medical necessity is established based on CDC and ACIP guidelines recommending annual influenza vaccination for individuals aged 6 months and older.Specific risk factors such as age, underlying medical conditions, and pregnancy may increase the recommendation's strength.

The clinical responsibility lies with the healthcare professional administering the vaccine. This includes appropriate patient selection, administering the vaccine correctly, and documenting the procedure completely.

IMPORTANT Prior to January 1, 2018, Q2039 was used for influenza virus vaccines not otherwise specified by other codes.After this date, CPT code 90756 should be used. Specific codes like Q2036, Q2037, and Q2038 existed for specific manufacturers' split virus vaccines.

In simple words: This code is for a specific type of flu shot (a split-virus vaccine) given as a shot in the muscle.It's used for people age 3 and older when a more specific flu shot code isn't available.

HCPCS code Q2039, effective August 1, 2017, designates an influenza virus vaccine (split virus) that is not otherwise specified by another HCPCS code.This code is specifically for intramuscular administration in individuals aged 3 years and older.It was used as a temporary code until CPT code 90756 was implemented on January 1, 2018.Complete documentation should include the National Drug Code (NDC) number, vaccine name, dosage, strength, doses per vial (if applicable), and the amount of drug per unit.

Example 1: A 65-year-old patient receives a split-virus flu vaccine in a physician's office. Q2039 is used because the specific manufacturer's vaccine is not specified by a different HCPCS code., A 4-year-old child receives an intramuscular flu shot at a health clinic.The specific brand is unknown, so Q2039 is used., A patient at a Federally Qualified Health Center (FQHC) receives an influenza vaccination. The administration is documented, and the specific brand of split virus influenza vaccine is identified using the NDC number.

Complete documentation must include: patient demographics, date of service, vaccine administered (including NDC number, manufacturer, and lot number), dosage, route of administration (intramuscular), site of administration, any adverse reactions, and provider signature.

** This code was a temporary measure.Always ensure that you are using the most current and accurate codes for influenza vaccines. Refer to the most current CMS guidelines and coding manuals.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.